Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics

News provided by

Mar 06, 2023, 14:30 ET

DUBLIN, March 6, 2023 /PRNewswire/ -- The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.

North America accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029.

Growing pharma R&D expenditure, increasing development of new drugs over the time, increasing approval of generics and biosimilars, growing biopharmaceutical drugs pipelines, presence of number of API manufacturing facilities for all regulated drug products, increasing scope of highly potent drugs, government support to expand the domestic pharmaceutical manufacturing facilities and increase in the prevalence of infectious diseases, cancer, central nervous system associated diseases, cardiac disease, and musculoskeletal disorder are some of the major diseases that are driving the market growth. Asia-Pacific is the fastest-growing region with a high single digit CAGR from 2022 to 2029.

The factors such as increasing generic pharmaceuticals and vaccines production, number of pharma companies with a strong network of manufacturing facilities, increasing outsourcing with number of CMO's and expanding manufacturing facilities, increasing development of new pharma and biopharma drugs, growing biotech R&D investment, presence of number of innovative biotech startups, presence of dedicated departments to support biotechnology research, increasing government investment to support the pharma and biotech industry, low labor cost, and increased prevalence of infectious and other chronic diseases are driving the market growth.

Some of the key players of Active pharmaceutical Ingredient (API) market are

Catalent Inc.
Divis Laboratories
Euroapi
Lonza Group Ltd.
Pfizer Inc.
Samsung Biologics Co. Ltd.
Teva Pharmaceutical Industries Limited.
Thermo Fisher Scientific Inc
Wuxi Apptec Co. Ltd.
Wuxi Biologics (Cayman) Inc.

Key Topics Covered:

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increasing Incidence and Prevalence of Chronic, Communicable and Autoimmune Diseases
3.3.1.2 Adoption of Biologics in Disease Management and Increasing Regulatory Approvals
3.3.1.3 Increasing Investment in Research and Development (R&D) and Expansion of Manufacturing Facilities
3.3.1.4 Patent Expiration of Major Drugs
3.3.1.5 Increasing Scope of Hpapi and Advanced Next Generation Biologics Market
3.3.1.6 Increasing Trend of Outsourcing and Adoption in Emerging Market
3.3.1.7 Increase in the Geriatric Population
3.3.2 Restraints and Threats
3.3.2.1 Contamination of API
3.3.2.2 High Cost for Manufacturing Apis
3.3.2.3 a Requirement of Highly Skilled Technicians
3.3.2.4 Pierce Competition Between API Players
3.3.2.5 Presence of Alternatives
3.3.2.6 Stringent Regulatory Policies and Environmental Concerns
3.4 Regulatory Affairs
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Automation and Control
3.5.3 Continuous Flow Manufacturing
3.5.4 Cryogenic Technology
3.5.5 Single - Use System (Sus)
3.5.6 Artificial Intelligence in API Manufacturing
3.5.7 Chemistry in Water
3.5.8 M-Rna Technology in Vaccine Manufacturing
3.5.9 Advancements in Hpapi Manufacturing
3.6 Porter's Five Force Analysis
3.7 Supply Chain Analysis
3.8 Market Share Analysis
3.9 Fda Approved API Manufacturing Units
3.10 Pharmaceutical API Production Volume
3.11 Patent Expiry and Anda Approvals
3.12 Drug Master Filing (Dmf)
3.13 Repurposed Drugs for COVID-19 Treatment
3.14 Acquisition, Merger, and Expansions in API Manufacturing
3.15 Selected Top Selling API
3.16 API Manufacturers Revenue and Capabilities Table

4 API Global Market, Based on Synthesis
4.1 Introduction
4.2 Synthetic API
4.2.1 Synthetic API Based on Customer Base
4.3 Biotech API
4.3.1 Antibodies
4.3.2 Recombinant Proteins
4.3.3 Vaccines
4.3.4 Gene Therapy
4.3.5 Cell Therapy
4.3.6 Other Biotech API
4.3.7 Biotech API Based on Customer Base
4.3.7.1 Biologic API
4.3.7.2 Biosimilar API
4.4 Hpapi
4.4.1 Hpapi Based on Customer Base

5 API Global Market, Based on Business Type
5.1 Introduction
5.2 Captive API Based on Type
5.2.1 Branded Captive API
5.2.2 Generic Captive API
5.3 Merchant API Based on Type
5.3.1 Branded Merchant API
5.3.2 Generic Merchant API

6 API Global Market, Based on Application
6.1 Introduction
6.2 Infectious Diseases
6.3 Oncology
6.4 Cardiovascular Diseases
6.5 Central Nervous System
6.6 Pulmonary Diseases
6.7 Gastrointestinal Diseases
6.8 Endocrine Diseases
6.9 Metabolic Disorders
6.10 Genitourinary Diseases
6.11 Musculoskeletal Diseases
6.12 Other Applications (Nephrology, Hepatology, Opthalmology, Dental, Pain Management, Dermatology,Ent Etc.,)

7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest of North America
7.3 Europe
7.3.1 Italy
7.3.2 Germany
7.3.3 France
7.3.4 Rest of Europe
7.4 APAC
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of APAC
7.5 RoW
7.5.1 Brazil
7.5.2 Rest of Latam
7.5.3 Middle East & Others

8 Competitive Landscape
8.1 Introduction
8.2 Collaboration, Partnership and Agreement
8.3 Expansion
8.4 Approvals
8.5 New Product, Service and Technology Launch
8.6 Acquisition
8.7 Others

9 Major Companies
9.1 Overview
9.2 Financials
9.3 Service Portfolio
9.4 Key Developments
9.5 Business Strategy
9.6 SWOT Analysis

Companies Mentioned

Aarti Drugs Ltd
AbbVie Inc.
ACIC Pharmaceuticals Inc.
Adimmune Corporation
Ajinomoto Bio-Pharma Services
Albemarle Corporation
Alembic Ltd
Alkem laboratories Ltd.
Almac Group
Alven Laboratories S.r.o.
Ambio Pharma Inc.
Amneal Pharmaceuticals Inc.
Apicore LLC
Aragen Life Sciences (GVK Biosciences Private Limited)
Arene Lifesciences Limited.
AstraZeneca plc
Aurobindo Pharma
Ampac fine chemicals LLC
Axplora
BASF SE
Bayer AG
Bachem holding AG
Bal Pharma Ltd.
Biocon Limited
Biogen Inc.
Biomarin Pharmaceutical Inc
Biophore India Pharmaceuticals Pvt. Ltd.
Biosortia Pharmaceuticals Inc.
Biotechnica Pharma Global
Blanver
Boehringer Ingelheim GmbH
Brawn Biotech Ltd.
Bristol-Myers Squibb Company
Cadila Pharmaceuticals Limited
Curia
Catalent, Inc.
Cayman Chemicals
Celltrion Inc.,
Cambrex Corporation
Century Pharmaceuticals Ltd
CFM Group (AMSA S.P.A)
Changzhou Pharmaceutical Factory
ChemCon GmbH
China Chemical & Pharmaceutical Co., Ltd.
Chongqing Huapont Pharmaceutical CO LTD,
Cipla Limited
CKD Bio
Corden Pharma International (Germany)
CSL Ltd
Daiichi Sankyo Chemical Pharma Co Ltd
Daito Pharmaceutical Co., Ltd
Dishman Carbogen Amcis
Dr.Reddy's Laboratories
Eisai Co., Ltd.
Eli Lilly and Company
Emcure Pharmaceuticals Ltd.
Ercros S.A.
Estechpharma Co., Ltd.
Esteve Quimica SA
Everest Organics Limited
Evonik Industries AG
F. Hoffmann-La Roche AG
Fareva Group
FIS Fabbrica Italiana Sintetici SPA
Flamma S.p.A
Formosa Laboratories, Inc.
Fuji Chemical Industry Co.,Ltd
Gentec Pharmaceutical Group S.A (DUKE CHEM and PHARMANOID)
Gilead Sciences, Inc.
Givaudan (Indena)
Gland Pharma Limited
GlaxoSmithKline plc
Glenmark Pharmaceutical Ltd.
GRANULES INDIA LTD.
Grupo Ferrer Internacional S.A (Interquim, S.A)
Harman Finochem Limited.
Heraeus Holding GmbH
Hetero Labs Ltd.
Hikma pharmaceuticals
Hybio Pharmaceutical Co., Ltd.
Hikal Ltd.
Ibio Inc
Inabata Co. Ltd.
INTAS PHARMACEUTICALS LTD,
Jeil Pharmaceutical Co. Ltd.,
Johnson and Johnson
Johnson Matthey Pharma Services Inc.
Jubilant lifesciences (Jubilant generics Ltd)
Katsura Chemical Co.,Ltd.
Kern Pharma, S.L.,
Kleos pharma
Kocak Farma Pharmaceutical
Kosher Pharmaceuticals
Krka, tovarna zdravil, d. d., Novo mesto
Kyowa Hakko Kirin
Laboratorium ofichem bv
Lannett Company Inc.
Laurus Labs
Lebsa
Lonza group
Lusochimica S.p.A
LOTUS Pharmaceutical Co., Ltd.
Lesaffre (Gnosis S.p.A.)
Magle Chemoswed AB
Mallinckrodt Pharmaceuticals
Medichem S.A
Megafine Pharma Ltd
Mehta API
Merck KGaA
Metrochem API
Micro Labs LTD
Minakem High Potent S.A.
Moehs Iberica SL
Molcan
Morepen
MSN Organics Pvt, Ltd.
Natco Pharma
Neuland laboratories Ltd.
Novartis International AG
Novo Holdings A/S
Olainfarm JSC
OLON S.P.A.
Orchid Chemicals & Pharmaceuticals Ltd
Orion (Fermion)
Optimus Drugs Private LTD.
Paratek Pharmaceuticals, Inc.
Perrigo Company plc,
Pfizer Inc.
Phyton Biotech LLC
Pierre Fabre
Polpharma
Prajna Generics Pvt. Ltd.
Protex International (ICROM S.p.A.)
Rablon Healthcare Pvt Ltd
Saneca Pharmaceuticals a.s.
Sanofi S.A.
Solara Active Pharma
Seikagaku Corporation
SEQUENS (Wavelength Pharmaceuticals)
Shiono Chemical Co., Ltd.
SM BIOMED SDN. BHD
Siegfried Holding AG
Standard Chemical & Pharmaceutical Co.
Sumitomo Dainippon Pharma Co., Ltd.
Sun Pharmaceutical Industries Ltd
Syn-tech chem. And Pharma.Co., Ltd
Takeda Pharmaceutical Company Limited
Temad Co.
Teva Pharmaceutical industries Ltd.
Umicore
Unichem Laboratories LTD.
Union Quimico Farmaceutica, S.A. UQUIFA,
Venus Remedies Limited
Vertex Pharmaceuticals Inc.

For more information about this report visit https://www.researchandmarkets.com/r/bcuwni

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets